HEARD — Investor Relations
Raising Series A  ·  Targeting first close Q3 2025
Investor relations

The patient voice
platform built
to scale.

HEARD is building the AI layer between patients and healthcare systems — turning silenced symptoms into documented, actionable advocacy at scale.

All materials are confidential and subject to NDA. Accredited investors only.

14K+ Waitlist patients
89% Better prepared
4.9★ Beta rating
B2B Employer pilots in progress

Request investor
materials.

Complete the form below to receive our investor brief. We review all submissions personally and respond within 24 hours to accredited investors.

What you'll receive
01

Pitch deck — market sizing, vision, traction

02

Financial model — revenue projections & unit economics

03

30-min founder call — with the HEARD founding team

The opportunity

A $40B problem hiding
in plain sight.

Medical errors, missed diagnoses, and patient miscommunication cost the US healthcare system over $40 billion annually. HEARD is the first AI platform built to close the communication gap from the patient side.

$40B Annual cost of miscommunication in US healthcare
1 in 3 Patients leave appointments without understanding their diagnosis
7 min Average time a doctor spends with a patient per visit
330M US patients who need a better way to communicate with their doctors
Why now

The conditions for HEARD
exist today.

Three converging forces make this the right moment to build patient advocacy at scale.

01 / 03

AI makes patient communication solvable — now

LLMs can now translate clinical language, detect symptom patterns, and generate appointment scripts with accuracy that wasn't possible three years ago. HEARD is the first consumer product built on this capability — not for clinicians, for patients.

02 / 03

330M patients have no tools on their side

Every clinical tool built in the last decade serves providers. Patients get a patient portal and a copay. The $40B communication gap between patient and provider is entirely unaddressed — and HEARD is the first AI product purpose-built to close it.

03 / 03

Employers are the fastest B2B path to scale

Employers spend $15K+ per employee on healthcare and have a direct financial incentive to reduce diagnostic delays and ER visits. HEARD's B2B channel gives us a recurring revenue stream with measurable ROI — and no consumer acquisition cost.

Traction

Built in public.
Validated by patients.

Every metric driven by word of mouth — zero paid acquisition to date.

14,000+ Waitlist signups — organic
4.9★ Beta user satisfaction score
89% Reported feeling better prepared at their next appointment
$0 Paid marketing spend to reach 14,000+ patients
The team

Built by people who understand
what patients need.

F

Founding Team

CEO & Co-founder

Former patient advocate and health tech operator. Built and sold two healthcare SaaS products. Deeply personal mission.

P

Product & Engineering

CTO & Co-founder

10 years in clinical informatics and patient-facing digital health. Previously led engineering at a Series B health startup.

A

Clinical Advisory

Medical Director

Practicing physician with 15 years of experience. Champions patient communication as the most underinvested area in medicine.

"HEARD isn't just a patient app — it's infrastructure. The communication layer healthcare never built."

HEARD INVESTOR BRIEF, 2025

Ready to learn more?
Let's talk.

Complete the form above or reach us directly. We respond to all accredited investors within 24 hours.

Series A · HEARD

Request investor brief